0
0
0
Calling for sickle cell trait research, surveillance, and public education and awareness, and for other purposes.
2/5/2024, 2:30 PM
Summary of Bill HRES 672
Bill 118 HRES 672, also known as the "Calling for sickle cell trait research, surveillance, and public education and awareness, and for other purposes" bill, was introduced in the US Congress with the aim of addressing the issues related to sickle cell trait.
The bill calls for increased research on sickle cell trait, a genetic condition that affects the shape of red blood cells and can lead to serious health complications. It also calls for improved surveillance of sickle cell trait in order to better understand its prevalence and impact on individuals.
Additionally, the bill emphasizes the importance of public education and awareness about sickle cell trait, in order to ensure that individuals with the condition are able to access appropriate care and support. Overall, the bill seeks to improve the understanding and management of sickle cell trait in the United States, with the ultimate goal of improving outcomes for individuals affected by this condition.
The bill calls for increased research on sickle cell trait, a genetic condition that affects the shape of red blood cells and can lead to serious health complications. It also calls for improved surveillance of sickle cell trait in order to better understand its prevalence and impact on individuals.
Additionally, the bill emphasizes the importance of public education and awareness about sickle cell trait, in order to ensure that individuals with the condition are able to access appropriate care and support. Overall, the bill seeks to improve the understanding and management of sickle cell trait in the United States, with the ultimate goal of improving outcomes for individuals affected by this condition.
Congressional Summary of HRES 672
This resolution recognizes the challenges posed by sickle cell trait and sickle cell disease and encourages relevant screening, research, and surveillance. Sickle cell disease is a group of inherited disorders that cause abnormally shaped red blood cells.
Read the Full Bill
Current Status of Bill HRES 672
Bill HRES 672 is currently in the status of Bill Introduced since September 8, 2023. Bill HRES 672 was introduced during Congress 118 and was introduced to the House on September 8, 2023. Bill HRES 672's most recent activity was Referred to the House Committee on Energy and Commerce. as of September 8, 2023
Bipartisan Support of Bill HRES 672
Total Number of Sponsors
1Democrat Sponsors
1Republican Sponsors
0Unaffiliated Sponsors
0Total Number of Cosponsors
2Democrat Cosponsors
2Republican Cosponsors
0Unaffiliated Cosponsors
0Policy Area and Potential Impact of Bill HRES 672
Primary Policy Focus
HealthAlternate Title(s) of Bill HRES 672
Calling for sickle cell trait research, surveillance, and public education and awareness, and for other purposes.
Calling for sickle cell trait research, surveillance, and public education and awareness, and for other purposes.
Comments
Sponsors and Cosponsors of HRES 672
Latest Bills
BETS OFF Act
Bill HR 7955March 28, 2026
FAIR ACT
Bill HR 7953March 28, 2026
Take Back Our Hospitals Act of 2026
Bill HR 7920March 28, 2026
FLARE Act
Bill HR 7929March 28, 2026
CODIS Access Modernization Act
Bill HR 7916March 28, 2026
IDA Act of 2026
Bill HR 7931March 28, 2026
Small Business Dependent Care FSA Opportunity Act
Bill HR 7922March 28, 2026
American Families First Assistance Act
Bill HR 7925March 28, 2026
Land Reparations Commission Act
Bill HR 7927March 28, 2026
Stop Fraud by SOMALIA Act
Bill HR 7923March 28, 2026

